Social media platforms are frequently where consumers find information about health care products. They're also where US regulatory agencies are finding unlawful claims for treating or preventing infections from the novel coronavirus.
The Food and Drug Administration and the Federal Trade Commission's four warning letters published on 1 April include the first firm marketing